Bronchogen is studied in tissue regeneration and repair research, including cell and animal models. Proposed, like other Khavinson short peptides, to enter bronchial epithelial cell nuclei and bind DNA promoter regions; one study measured a stabilizing effect on DNA melting temperature in vitro. This peptide-DNA mechanism remains a largely unproven hypothesis.
Studied in the context of chronic airway disease; one rat study of obstructive lung pathology reported regression of bronchial epithelial remodeling. No controlled human trials exist.
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
We reply personally – via email or Telegram.